> Charles Richard Jones
Richard has over 30 years of experience in clinical research and product development in large pharmaceutical companies, biotech’s and CRO companies. His experience spans all phases of drug development and includes both biologics and small molecules.
His experience in Big Pharma including Vice President for Drug Evaluation at Johnson & Johnson and Leader /Clinical Scientist /Pharmacologist at Hoffmann-La Roche.
His CRO industry: As the Vice President of General Medicine and Scientific Affairs in inVentiv Health Clinical he led the internal medicine medical group encompassing cardiovascular, rheumatology, respiratory and infectious disease. In Quintiles as the Vice President and Therapeutic Strategy Head he headed Immunology and Internal Medicine group. In Biotech: Chief Medical Officer for Syntaxin, Aspreva and Syngenta.
Richard authored over 80 publications in peer reviewed journals and has presented on drug development with over 60 presentations at international meetings. He is a member of the ECPM teaching faculty University of Basel and holds several patents.
Richard is a licensed UK physician with medical degrees from the Universities of Cambridge and Oxford and member of the Royal College of Physicians MRCP (UK).